" " Drug Treating Post-Partum Depression Acts on Inflammation – Wellness for Life " "
Wellness for Life
Advertisement
  • Home
  • News
  • Family Wellness
  • Health and Wellbeing
  • Mental Wellness
  • Contact us
No Result
View All Result
  • Home
  • News
  • Family Wellness
  • Health and Wellbeing
  • Mental Wellness
  • Contact us
No Result
View All Result
Wellness for Life
No Result
View All Result
Home News

Drug Treating Post-Partum Depression Acts on Inflammation

admin by admin
March 12, 2023
in News


They found that brexanolone inhibited the toll-like receptors responsible for the production of cytokines and chemokines – the markers of inflammation. Toll-like receptors are like gatekeepers on the surface of cells, recognizing molecules and then initiating a cell’s inflammatory response.

These results provide the first human data showing that blockade of specific inflammatory pathways is likely involved, at least in women who were unresponsive to other medications. Their results were published in eBioMedicine.

Advertisement


According to recent studies, one in eight women experience post-partum depression symptoms, and the prevalence of depression diagnoses at delivery is rising. The CDC reports that rates in 2015 were seven times higher than they were in 2000. However, scientists are still unsure of what causes PPD to develop in the brain.

One potential cause of PPD could be a deficiency in GABAergic transmission, which calms the brain via a neurotransmitter known as GABA. GABA, or y-Aminobutyric acid, is found in our central nervous systems and instructs our bodies to stop, or inhibit, the activity of neurons. Additionally, PPD could also be caused by deficits in our normal responses to stress.

But recent data and this new study suggest that inflammation may be contributing to the syndrome. Much like other types of depression, PPD is typically treated with SSRIs, but sometimes patients don’t improve with conventional therapy.

Now, doctors can prescribe brexanolone in such circumstances. Brexanolone was initially approved in 2019, but the mechanism underlying its antidepressant action was unclear at the time.

By the same reasoning, brexanolone or other anti-inflammatory drugs may also be effective for treating other types of depression that elevate inflammatory markers. The team hopes that their new findings may lead to more cost-effective treatments that can block the same inflammatory pathways that were identified in the study.

Source: Eurekalert



Source link

Tags: antidepressantsbrexanolone for post-partum depressiondepression in womeninflammation in depressionPost-partum depression
Previous Post

Women’s health startup Iron Health launches with $4.5M

Next Post

Are second pregnancies harder than the first?

Next Post

Are second pregnancies harder than the first?

Recommended

50 calming affirmations for Christmas chaos

December 19, 2022

What is sleep syncing, and how can you try it?

March 3, 2023

Don't miss it

Health and Wellbeing

‘Zoned Priming’ Combats Springtime Oil Without Leaving You Fully Matte

April 1, 2023
Health and Wellbeing

Collagen Cookie Dough – Fit Foodie Finds

March 31, 2023
Mental Wellness

Common Barriers to Seeking Addiction Treatment

March 31, 2023
News

Telemedicine Improves Quality of Care for Depression

March 31, 2023
News

Experts ‘cautiously optimistic’ about extended reality for mental healthcare

March 31, 2023
News

Will They Try to Make Us Pay for Breathable Air?

March 31, 2023

© Wellness For Life News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Family Wellness
  • Health and Wellbeing
  • Mental Wellness
  • Contact us

Newsletter Sign Up

Loading
No Result
View All Result
  • Home
  • News
  • Family Wellness
  • Health and Wellbeing
  • Mental Wellness
  • Contact us

© 2022 Wellness For Life News Hubb All rights reserved.